Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Quoin Pharmaceuticals (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company specializing in rare and orphan diseases, has scheduled its Q2 2025 financial results release for August 7, 2025, before market opening.
The upcoming announcement will feature both financial results for the quarter ending June 30, 2025, and an operational update covering the company's key achievements and recent milestones.
Quoin Pharmaceuticals (NASDAQ: QNRX), un'azienda farmaceutica specializzata in malattie rare e orfane in fase clinica avanzata, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 7 agosto 2025, prima dell'apertura del mercato.
L'annuncio includer脿 sia i risultati finanziari relativi al trimestre terminato il 30 giugno 2025, sia un aggiornamento operativo con i principali traguardi e recenti progressi dell'azienda.
Quoin Pharmaceuticals (NASDAQ: QNRX), una empresa farmac茅utica especializada en enfermedades raras y hu茅rfanas en etapa cl铆nica avanzada, ha programado la publicaci贸n de sus resultados financieros del segundo trimestre de 2025 para el 7 de agosto de 2025, antes de la apertura del mercado.
El pr贸ximo anuncio incluir谩 tanto los resultados financieros del trimestre que finaliza el 30 de junio de 2025 como una actualizaci贸n operativa con los principales logros y avances recientes de la compa帽铆a.
Quoin Pharmaceuticals (NASDAQ: QNRX)電� 頋穩 氚� 瓿犾晞 歆堩櫂鞚� 鞝勲鞙茧 頃橂姅 頉勱赴 鞛勳儊 雼硠鞚� 鞝勲 鞝滌暯須岇偓搿�, 2025雲� 8鞗� 7鞚� 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 鞁滌灔 臧滌灔 鞝�鞐� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟.
鞚措矆 氚滍憸鞐愲姅 2025雲� 6鞗� 30鞚茧 膦呺霅橂姅 攵勱赴鞚� 鞛 鞁れ爜瓿� 須岇偓鞚� 欤检殧 靹标臣 氚� 斓滉芳 鞚挫爼響滊ゼ 韽暔頃� 鞖挫榿 鞐呺嵃鞚错姼臧� 韽暔霅� 鞓堨爼鞛呺媹雼�.
Quoin Pharmaceuticals (NASDAQ : QNRX), une soci茅t茅 pharmaceutique sp茅cialis茅e en phase clinique avanc茅e dans les maladies rares et orphelines, a pr茅vu la publication de ses r茅sultats financiers du deuxi猫me trimestre 2025 pour le 7 ao没t 2025, avant l'ouverture des march茅s.
L'annonce 脿 venir comprendra 脿 la fois les r茅sultats financiers du trimestre clos le 30 juin 2025 et une mise 脿 jour op茅rationnelle pr茅sentant les principales r茅alisations et 茅tapes r茅centes de l'entreprise.
Quoin Pharmaceuticals (NASDAQ: QNRX), ein spezialisiertes Pharmaunternehmen in der sp盲ten klinischen Phase mit Fokus auf seltene und vernachl盲ssigte Krankheiten, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 7. August 2025 vor B枚rsen枚ffnung geplant.
Die bevorstehende Bekanntgabe umfasst sowohl die Finanzergebnisse f眉r das Quartal bis zum 30. Juni 2025 als auch ein operatives Update zu den wichtigsten Erfolgen und j眉ngsten Meilensteinen des Unternehmens.
- None.
- None.
ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025.
The announcement will include an operational update highlighting key achievements from the quarter, recent accomplishments, and financial highlights.
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin鈥檚 innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, go to: .
For further information, contact:
Quoin Pharmaceuticals Ltd.
Michael Myers, Ph.D., CEO
听
Investor Relations
PCG Advisory
Jeff Ramson
听
(646) 863-6341
FAQ
When will Quoin Pharmaceuticals (QNRX) release its Q2 2025 earnings?
What period will Quoin Pharmaceuticals' Q2 2025 earnings cover?
What will be included in Quoin Pharmaceuticals' Q2 2025 earnings announcement?
What is Quoin Pharmaceuticals' (QNRX) main business focus?
